Pharmafile Logo

Pioneering Paths: Women Leadership in Rare Disease

Rare diseases are often thought of as affecting one in 100,000 or one in 1,000,000 people, and that is true for some conditions. But there are many rare diseases that are more common. It may surprise many to learn that a condition that’s considered rare has a prevalence of 1 in 2000 or lower, and rare diseases overall affect more than 300 million people worldwide.

- PMLiVE

When a rare genetic condition runs in your family, when you see the impact it has, and you grow up alongside a rare disease patient advocacy group started by your parents, you gain quite a lot of lived experience, says Lucy McKay, MD. “There was so much that I learned and saw.”

As McKay made her way through medical school she was disheartened to find that medicine and the NHS [National Health Service] were not receptive to her experience and accumulated knowledge. They didn’t recognize the common challenges in rare disease, they did not include rare disease patients in medical studies, and they weren’t preparing future clinicians to support rare disease patients and their families. “It was impossible for me to stay working in that environment,” McKay says. “I could not do the career I chose.”

So what to do? If you are McKay, you grab your medical degree and start the UK-based charity Medics4RareDiseases (and also become a steering committee member of Medscape Education’s rare disease initiative).  

In fact, she says, it’s not surprising that most rare disease advocacy leaders are women. “Approximately 70 to 75 percent of rare conditions present solely in childhood, and a similar proportion are genetic conditions. The caregivers are more likely to be female, see the signs earlier, and be living that experience with their child as their needs become more obviously understood. 

“When women get activated, what do they get activated by? In rare disease, it’s because these needs are wholly unmet,” says McKay. “There’s no one out there coordinating this drive to help their children or to help their other loved ones.” So women step in and start making a lot of noise because they have no choice.

Abigail Epstein, head of communications and patient advocacy for Takeda UK and Ireland, may not have grown up in a family of advocates, but she is no less passionate about helping to improve the lives of everyone affected by a rare condition in a world that really doesn’t understand their needs. “I’ve taken inspiration from the community, which has this incredible ability to work together for the betterment of one another and what needs to be done—against incredibly difficult odds. 

Epstein works on a campaign called I am number 17, to raise awareness of the fact that one in 17 people are affected by a rare disease at some point in their lifetime. Worldwide, rare diseases affect roughly 263 to 446 million people.  That statistic, Epstein says, originated from Genetic Alliance but was not well recognized outside the rare community. “As a group,” she says, “we wanted to change that. Because though individually rare, rare conditions are collectively common.” 

And things are starting to change, she says. That one in 17 statistic is now a common part of discourse when rare diseases are looked at. And now more than ever, pharmaceutical companies have a lot in the pipeline for rare diseases. 

The pharmaceutical industry is also leading the way when it comes to employing and supporting women. Though women are the driving force for change in rare disease, McKay and Epstein both acknowledge that the leap from kitchen table charity work to chairing a disease conference can be a hurdle. “When you start looking at organizations that work in rare that are profit-making or anyone who’s in a decision-making role, suddenly the room starts to become more male,” McKay says. “Even though this industry was built on female advocacy.” 

A 2021 workplace study from the Association of the British Pharmaceutical Industry “found that women make up more than 54% of the pharma workforce in England,” Epstein says. “At Takeda, I’m proud of the fact that 56% of the general managers across Europe and Canada are women. It’s really important to continue that momentum, encouraging women to pursue careers in science and technology, whether that be through mentorships or other opportunities, making a conscious effort to promote women into leadership.”

Hosted by Christy Rohani-Montez, PhD, Director of Clinical Strategy at Medscape Education Global

Follow us on LinkedIn for updates on upcoming podcasts and more insightful conversations.

For more information, please contact Jelena Spyropoulos (Global) or Piyali Shin (US).

To learn more about rare diseases, visit Medscape’s Pathways in Rare Disease, https://www.medscape.org/sites/advances/rare-diseases, Medics for Rare Diseases, m4rd.org, or I am Number Seventeen at iamnumber17.org.uk

About Medscape Education Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free accredited CME and CE courses for physicians, nurses, and other healthcare professionals.

 

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

Being Rare Together: Medscape Education Sponsors the 2025 Cholestatic Liver Disease Summit

Medscape Education is a proud sponsor of the inaugural 2025 Cholestatic Liver Disease Summit, taking place June 26–28 in Aurora, Colorado, at the Hyatt Regency Aurora-Denver Conference Center. Hosted in...

New Alzheimer’s Treatments Are Driving a Shift in Earlier Detection and Clinician Education Engagement

June is Brain and Alzheimer’s Awareness Month — a chance to examine real-world data that links new treatments to changing clinical behavior.

“Humanizing Healthcare, Humanizing Education: The Power of Patient Integration”

Victoria Harvey-Jones, PhD, Clinical Strategist (Oncology) and Worldwide Patient Integration Lead to Present at the 2025 Patient Centricity & Engagement Conference

Driving Impact in Diabetes Care: Medscape to Present 11 Publications at ADA’s 85th Scientific Sessions

Medscape Education is proud to present 11 publications at the American Diabetes Association 85th Scientific Sessions, taking place June 20–23 in Chicago. These presentations reflect our commitment to advancing diabetes care...

Medscape Education Celebrates 30 Years of Impact with Launch of The Center of Excellence for Instructional Design

Medscape Education, a global leader in healthcare education, proudly announces the official launch of its Center of Excellence for Instructional Design—a central hub of expertise and strategic capability, dedicated to...

Medscape at the American Diabetes Association’s 85th Scientific Sessions: Your Sweet Spot for Innovation!

The American Diabetes Association’s 85th Scientific Sessions is almost here, and Medscape is ready to make an impact in the world of diabetes care! With two groundbreaking symposia, 11 dynamic...

Sharing Educational Outcomes at EHA 2025

Medscape Hematology will be at EHA 2025 to showcase the power of education impact through online abstracts, posters, and 4 symposia.

30 Years of Innovation in Education at HLTH Europe

The Medscape Education Global team will be travelling to Amsterdam for the HLTH Europe 2025 conference to showcase the power and value of CME. As pioneers in clinician education for...

Medscape Online Continuing Medical Education Led to New Diagnoses in Alzheimer’s Disease

Medscape Education has recently published a study looking at the real-world impact of online continuing medical education on Alzheimer's disease diagnosis. Read the full article here.  The study, published in...

Medscape Oncology at ASCO 2025: Driving Innovation, Education & Better Patient Outcomes

Medscape Oncology is making a powerful impact at ASCO 2025, bringing seven high-impact symposia, new research insights, and the return of the Medscape Fellows Program—all aimed at educating the next...